NOBILI, Bruno
 Distribuzione geografica
Continente #
EU - Europa 7.082
NA - Nord America 4.145
AS - Asia 2.916
SA - Sud America 419
AF - Africa 25
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 2
Totale 14.595
Nazione #
RU - Federazione Russa 4.316
US - Stati Uniti d'America 4.075
SG - Singapore 1.005
CN - Cina 796
IE - Irlanda 787
UA - Ucraina 466
HK - Hong Kong 412
GB - Regno Unito 377
BR - Brasile 360
IT - Italia 342
DE - Germania 281
VN - Vietnam 268
SE - Svezia 155
FI - Finlandia 124
IN - India 121
TR - Turchia 103
FR - Francia 85
GR - Grecia 69
KR - Corea 57
JP - Giappone 54
CA - Canada 37
AR - Argentina 24
BE - Belgio 20
BD - Bangladesh 18
PL - Polonia 16
MX - Messico 15
IQ - Iraq 10
CZ - Repubblica Ceca 9
SA - Arabia Saudita 9
EC - Ecuador 8
NL - Olanda 8
PH - Filippine 8
ZA - Sudafrica 8
ES - Italia 7
IR - Iran 7
PY - Paraguay 7
CO - Colombia 6
UZ - Uzbekistan 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
EU - Europa 5
AT - Austria 4
CL - Cile 4
CR - Costa Rica 4
DO - Repubblica Dominicana 4
ID - Indonesia 4
KZ - Kazakistan 4
PK - Pakistan 4
PT - Portogallo 4
TN - Tunisia 4
DZ - Algeria 3
GE - Georgia 3
MY - Malesia 3
AU - Australia 2
AZ - Azerbaigian 2
EG - Egitto 2
IS - Islanda 2
JM - Giamaica 2
JO - Giordania 2
KE - Kenya 2
KW - Kuwait 2
MA - Marocco 2
MD - Moldavia 2
MQ - Martinica 2
NP - Nepal 2
PE - Perù 2
PS - Palestinian Territory 2
SN - Senegal 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CH - Svizzera 1
EE - Estonia 1
ET - Etiopia 1
GT - Guatemala 1
HN - Honduras 1
IL - Israele 1
LT - Lituania 1
LV - Lettonia 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
QA - Qatar 1
RO - Romania 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
YE - Yemen 1
Totale 14.595
Città #
Moscow 1.535
Dublin 786
Jacksonville 694
Chandler 596
Hong Kong 406
Singapore 400
Santa Clara 363
San Jose 316
Ashburn 169
Ann Arbor 125
Princeton 120
Medford 111
Boardman 104
Bengaluru 103
Hefei 98
Beijing 97
San Mateo 87
Ho Chi Minh City 79
Wilmington 78
Dallas 72
Hanoi 71
Caserta 69
Woodbridge 69
Nanjing 62
Seoul 56
Bremen 48
New York 39
Munich 31
Cambridge 30
Roxbury 29
Los Angeles 27
São Paulo 27
The Dalles 27
Dearborn 21
Düsseldorf 21
Istanbul 21
Kunming 21
Brussels 20
Naples 20
Jinan 19
Da Nang 16
Guangzhou 16
Mountain View 16
Des Moines 15
Napoli 15
Warsaw 15
Chicago 14
Grumo Nevano 13
Haiphong 13
Nanchang 13
Auburn Hills 12
Belo Horizonte 12
Curitiba 12
Tianjin 12
Atlanta 11
Council Bluffs 11
Norwalk 11
Orem 11
Rio de Janeiro 11
Zhengzhou 11
Frankfurt am Main 10
Elora 9
Hangzhou 9
Boston 8
Milan 8
Shenyang 8
Brno 7
Hebei 7
Helsinki 7
Hillsboro 7
Houston 7
London 7
Montreal 7
Nha Trang 7
Toronto 7
Brooklyn 6
Memphis 6
Ningbo 6
Redwood City 6
Riyadh 6
San Francisco 6
Shanghai 6
Tashkent 6
Bắc Ninh 5
Johannesburg 5
Lanzhou 5
Nocera Inferiore 5
Porto Alegre 5
Rome 5
Amsterdam 4
Asunción 4
Baghdad 4
Brasília 4
Campinas 4
Caracas 4
Centrale 4
Changchun 4
Changsha 4
Cutrofiano 4
Dhaka 4
Totale 7.564
Nome #
Association between cannabinoid receptor type 2 Q63R variant and oligo/polyarticular juvenile idiopathic arthritis 250
Cannabinoid receptor 2 as anti-obesity target: inflammation, fat storage and browning modulation. 206
Cannabinoid receptor 2-63 QQ varianti s associated with severe necroinflammation in chronic epatiti C 205
Cannabinoid receptor 2 Q63R variant could modulate the relationship between childhood obesity and age at menarche 196
Association Between a Polymorphism in Cannabinoid Receptor 2 and Severe Necroinflammation in Patients With Chronic Hepatitis C. 191
Iron overload enhances human mesenchymal stromal cell growth and hampers matrix calcification 187
Endocannabinoid Research Group (ERG), Italy. The endovanilloid/endocannabinoid system: a new potential target for osteoporosis therapy. 186
CNR2 functional variant (Q63R) influences childhood immune thrombocytopenic purpura. 186
A case of cutaneous mastocytosis associated with A-G dysgammaglobulinemia 182
Congenital erythrocytosis associated with gain-of-function HIF2A gene mutations and erythropoietin levels in the normal range. 181
Endocrine function and bone disease during long-term chelation therapy with deferasirox in patients with β-thalassemia major. 172
[Sanfilippo's disease of type B. Study of the enzymatic deficiency in a family] 164
PKCβII-mediated cross-talk of TRPV1/CB2 modulates the glucocorticoid-induced osteoclast overactivity 160
EPO receptor gain-of-function causes hereditary polycythemia, alters CD34 cell differentiation and increases circulating endothelial precursors. 158
Ematologia 158
The cannabinoid receptor type 2 Q63R variant increases the risk of celiac disease: implication for a novel molecular biomarker and future therapeutic intervention. 157
Vitamin A and infancy. Biochemical, functional, and clinical aspects 156
Vitamin A and infancy. Biochemical, functional, and clinical aspects 156
Association of the cannabinoid receptor 2 (CB2) Gln63Arg polymorphism with indices of liver damage in obese children: An alternative way to highlight the CB2 hepatoprotective properties. 154
The 17-β-oestradiol inhibits osteoclast activity by increasing the cannabinoid CB2 receptor expression. 153
A modification of the 'pink test' may improve the diagnosis of hereditary spherocytosis 153
[Fluorimetric determination of erythrocytic free protoporphyrins in evaluation of iron deficiency states] 153
The cannabinoid receptor type 2 as mediator of mesenchymal stromal cell immunosuppressive properties. 152
The N-terminal 11 amino acids of human erythrocyte band 3 are critical for aldolase binding and protein phosphorylation: implications for band 3 function 151
ERITROCITOSI CONGENITA CAUSATA DA ALTERAZIONI DEL SISTEMA SENSORE DELL’OSSIGENO 150
The genetic ablation or pharmacological inhibition of TRPV1 signalling is beneficial for the restoration of quiescent osteoclast activity in ovariectomized mice. 145
CB2 and TRPV1 receptors oppositely modulate in vitro human osteoblast activity 144
[Hematological screening of a group of children from a school population] 144
[Antibiotic therapy: cephalosporins] 143
Concordanza tra visita oculistica e RM encefalo nello screening del glioma delle vie ottiche nei pazienti pediatrici con neurofibromatosi tipo 1 143
Spectrum of FANCA mutations in Italian Fanconi anemia patients: identification of six novel alleles and phenotypic characterization of the S858R variant 141
[Current possibilities of the use of ferritin in clinical diagnosis] 141
Iron overload causes osteoporosis in Thalassemia Major patients through interaction with TRPV1 channels. 140
The 17-estradiol inhibits osteoclast activity by increasing the cannabinoid CB2 receptor expression 140
[Glycerol test in thalassemia diagnosis (author's transl)] 139
[Diagnostic methods in iron deficiency states. Comparative data on free protoporphyrins of erythrocytes in iron deficiency states and in thalassemia] 138
[Alpha thalassemia in Campania: results of a survey of 319 newborn infants] 138
[Prevention therapy of infections in the course of granulocytopenia] 137
The endovanilloid/endocannabinoid system: A new potential target for osteoporosis therapy 136
[A case of progeria associated with Uhl's syndrome] 136
[Comparative evaluation of the activity "in vitro" of 4 aminoglycosides (gentamycin, sisomicin, tobramycin, amikacin)] 135
[The L-dopa test in diagnosis of pituitary dwarfism] 134
Von Hippel-Lindau-dependent polycythemia is endemic on the island of Ischia: identification of a novel cluster. 133
Effects of nebivolol on human platelet aggregation 133
Infant hypervitaminosis A causes severe anemia and thrombocytopenia: evidence of a retinol-dependent bone marrow cell growth inhibition 131
[An unusual salt-losing syndrome: pseudohypoaldosteronism. Description of a case] 131
Amoxicillin-induced hemolytic anemia in a child with glucose 6-phosphate isomerase deficiency 131
Interaction between metabotropic and NMDA glutamate receptors participate in the periaqueductal grey pain modulatory system 129
[Problems of antibiotic therapy in pediatrics] 129
[Very unusual combination: congenital nephrosis and bilateral congenital glaucoma] 126
Studio retrospettivo sulle complicanze emato-oncologiche nella neurofibromatosi tipo 1 in età pediatrica 126
Frequent de novo monoallelic expression of beta-spectrin gene (SPTB) in children with hereditary spherocytosis and isolated spectrin deficiency 125
Apparently normal ankyrin content in unsplenectomized hereditary spherocytosis patients with the inactivation of one ankyrin (ANK1) allele 125
Diamond-Blackfan anemia: expansion of erythroid progenitors in vitro by IL-9, but exclusion of a significant pathogenetic role for the IL-9 gene and the hematopoietic gene cluster on chromosome 5q 124
[Fetal hemoglobin during the first year of life: evaluation of total erythrocytes, neocytes and gerocytes] 124
The endovanilloid/endocannabinoid system in human osteoclasts: Possible involvement in bone formation and resorption 124
[Cartilage-hair hypoplasia: clinical and immunological study] 122
Neridronate improves bone mineral density and reduces back pain in β-thalassaemia patients with osteoporosis: results from a phase 2, randomized, parallel-arm, open-label study 121
[Prenatal diagnosis: current knowledge and future prospects] 121
The DMT1 IVS4+44C>A polymorphism and the risk of iron deficiency anemia in children with celiac disease 121
Erythrocyte membrane protein alterations underlying clinical heterogeneity in hereditary spherocytosis 120
Moyamoya syndrome in children with neurofibromatosis type 1: Italian-French experience 118
Treatment with short-term, high-dose cyclosporin A in children with refractory chronic idiopathic thrombocytopenic purpura 114
Long-term efficacy of deferasirox for cardiac siderosis in thalassemia major 114
Rituximab (anti-CD20 monoclonal antibody) in children with chronic refractory symptomatic immune thrombocytopenic purpura: efficacy and safety of treatment 112
Hereditary spherocytosis due to a novel frameshift mutation in AE1 cytoplasmic COOH terminal tail: band 3 Vesuvio 110
Reversible erythrocyte skeleton destabilization is modulated by beta-spectrin phosphorylation in childhood leukemia 109
La prevenzione dell’anemia mediterranea in Campania: stato attuale e prospettive 109
Esame emocromocitometrico 109
L1 effects on reactive oxygen (ROS) and nitrogen species (RNS) release, hemoglobin oxidation, low molecular weight antioxidants, and antioxidant enzyme activities in red and white blood cells of thalassemic patients 108
Effect of eradication of Helicobacter pylori in children with chronic immune thrombocytopenia: a prospective, controlled, multicenter study. 105
Bilateral neuroretinitis in a 6-year-old boy with acquired toxoplasmosis 105
ROBO2 gene variants are associated with familial vesicoureteral reflux 104
Membranous glomerulopathy in children given allogeneic hematopoietic stem cell transplantation 104
Spectrin/band 3 ratio as diagnostic tool in hereditary spherocytosis 104
Le anemie diseritropoietiche 104
Diamond-Blackfan anaemia in the Italian population 104
Rituximab for the treatment of refractory autoimmune hemolytic anemia in children 104
REPORT OF ADVERSE TRANSFUSION REACTIONS: EMOCOMPONENTS VIA APHERESIS VS WHOLE BLOOD INPEDIATRIC PATIENTS 104
COINHERITANCE OF GILBERT SYNDROME INCREASES THE RISK FOR DEVELOPING GALLSTONES IN PATIENTS WITH HEREDITARY SPHEROCYTOSIS 103
Clinical and biochemical study of thalassemia intermedia in Campania (southern Italy) 103
Long-term follow-up analysis after rituximab therapy in children with refractory symptomatic ITP: identification of factors predictive of a sustained response 102
Recombinant erythropoietin therapy as an alternative to blood transfusions in infants with hereditary spherocytosis 102
Factors influencing post-transfusional platelet increment in pediatric patients given hematopoietic stem cell transplantation 102
Long term efficacy of iron chelation therapy with deferasirox on endocrine function in thalassemia major 102
Management of acute childhood idiopathic thrombocytopenic purpura according to AIEOP consensus guidelines:assessment of Italian experience 101
Flow-cytometric analysis of erythrocytes and reticulocytes in congenital dyserythropoietic anaemia type II (CDA II): value in differential diagnosis with hereditary spherocytosis 101
ROBO2 gene variants are associated with familial vesicouretral reflux 101
Clinical and molecular evaluation of non-dominant hereditary spherocytosis 101
Serum Hepcidin and Iron Absorption in Pediatric Inflammatory Bowel Disease. 101
Anti-CD20 monoclonal antibody (Rituximab) for life-threatening autoimmune haemolytic anaemia in a patient with systemic lupus erythematosus 100
The outcome of children with Fanconi anemia given hematopoietic stem cell transplantation and the influence of fludarabine in the conditioning regimen: a report from the Italian pediatric group 99
Erythropoietin treatment can prevent blood transfusion in infantile pyknocytosis 99
Molecular heterogeneity of hereditary elliptocytosis in Italy 99
EVALUATION OF BODY IRON STATUS IN ITALIAN CARRIERS OF BETA-THALASSEMIA TRAIT 98
Gender- and age-related distinctions for the in vivo prooxidant state in Fanconi anaemia patients 98
Bart's hemoglobin in newborn infants of Campania 98
Terapia con rHu Epo in un caso di diabete mellito “early onset” ed anemia aplastica normocitica 98
Gilbert's syndrome accounts for the phenotypic variability of congenital dyserythropoietic anemia type II (CDA-II) 97
Anti-CD20 monoclonal antibody for the treatment of severe, immune-mediated, pure red cell aplasia and hemolytic anemia 97
Totale 13.130
Categoria #
all - tutte 48.913
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.913


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022763 96 8 7 18 257 7 13 19 27 72 66 173
2022/20231.814 144 40 27 205 206 176 3 134 804 13 33 29
2023/2024537 69 14 22 65 196 29 15 25 4 0 29 69
2024/20251.649 9 18 19 71 288 154 274 160 241 224 108 83
2025/20267.075 256 322 340 300 587 4.075 405 244 234 132 138 42
2026/202733 33 0 0 0 0 0 0 0 0 0 0 0
Totale 14.790